Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome

Journal of Steroid Biochemistry and Molecular Biology

Volumn 141, Issue , 2014, Pages 71-76

  Tepavčević, Snežana ^a   Vojnović Milutinović, Danijela ^b   Macut, Djuro ^b   Žakula, Zorica ^a   Nikolić, Marina ^b   Božić Antić, Ivana ^b   Romić, Snježana ^a   Bjekić Macut, Jelica ^c   Matić, Gordana ^b   Korićanac, Goran ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Medical Center Bezanijska Kosa   (Serbia)

Author keywords

Dihydrotestosterone; Glucose transporters; Heart; Insulin signaling pathway; Polycystic ovary syndrome

Indexed keywords

DIHYDROTESTOSTERONE; GLUCOSE TRANSPORTERS; HEART; INSULIN SIGNALING PATHWAY; POLYCYSTIC OVARY SYNDROME;

ANIMALS; BIOLOGICAL TRANSPORT; DIHYDROTESTOSTERONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; MYOCARDIUM; PHOSPHORYLATION; POLYCYSTIC OVARY SYNDROME; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84893964210     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.01.006     Document Type: Article

References (45)

1. G.W. Bates, and R.S. Legro Longterm management of polycystic ovarian syndrome (PCOS) Mol. Cell. Endocrinol. 373 2013 91 97
2. R. Azziz, E. Carmina, and D. Dewailly et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report Fertil. Steril. 91 2009 456 488
3. D. Apter How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism J. Endocrinol. Invest. 21 1998 613 617 (Pubitemid 28532468)
4. S. Franks Adult polycystic ovary syndrome begins in childhood Best Pract. Res. Clin. Endocrinol. Metab. 16 2002 263 272
5. J. Bronstein, S. Tawdekar, and Y. Liu et al. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought J. Pediatr. Adolesc. Gynecol. 24 2011 15 20
6. M. Fassnacht, N. Schlenz, and S.B. Schneider et al. Beyond adrenal and ovarian androgen generation: increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 88 2003 2760 2766 (Pubitemid 36724453)
7. M.E. Silfen, M.R. Denburg, and A.M. Manibo et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents J. Clin. Endocrinol. Metab. 88 2003 4682 4688 (Pubitemid 37357512)
8. L. Manneras, S. Cajander, and A. Holmang et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome Endocrinology 148 2007 3781 3791 (Pubitemid 47105840)
9. E. Diamanti-Kandarakis, and A. Dunaif Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications Endocr. Rev. 33 2012 981 1030
10. F. Iliadis, N. Kadoglou, and T. Didangelos Insulin and the heart Diabetes Res. Clin. Pract. 93 Suppl. 1 2011 S86 S91
11. B.J. DeBosch, and A.J. Muslin Insulin signaling pathways and cardiac growth J. Mol. Cell. Cardiol. 44 2008 855 864
12. J.J. Luiken, S.L. Coort, and D.P. Koonen et al. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters Pflugers Arch. 448 2004 1 15 (Pubitemid 38657200)
13. E. Diamanti-Kandarakis, and A.G. Papavassiliou Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol. Med. 12 2006 324 332 (Pubitemid 44094292)
14. E. Kassi, and E. Diamanti-Kandarakis The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome J. Endocrinol. Invest. 31 2008 1124 1131
15. A. Corbould, Y.B. Kim, and J.F. Youngren et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling Am. J. Physiol. Endocrinol. Metab. 288 2005 E1047 E1054
16. A. Dunaif, X. Wu, and A. Lee et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS) Am. J. Physiol. Endocrinol. Metab. 281 2001 E392 E399
17. K. Hojlund, D. Glintborg, and N.R. Andersen et al. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment Diabetes 57 2008 357 366
18. A. Corbould, H. Zhao, and S. Mirzoeva et al. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome Diabetes 55 2006 751 759 (Pubitemid 43343232)
19. M. Rajkhowa, S. Brett, and D.J. Cuthbertson et al. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo Biochem. J. 418 2009 665 671
20. T.P. Ciaraldi, V. Aroda, and S. Mudaliar et al. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance J. Clin. Endocrinol. Metab. 94 2009 157 163
21. Y.L. Chu, Y.Y. Sun, and H.Y. Qiu et al. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome] Zhonghua Fu Chan Ke Za Zhi 39 2004 176 179
22. D. Rosenbaum, R.S. Haber, and A. Dunaif Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes Am. J. Physiol. 264 1993 E197 E202
23. A. Corbould, and A. Dunaif The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome Metabolism 56 2007 716 722 (Pubitemid 46574736)
24. C.B. Book, and A. Dunaif Selective insulin resistance in the polycystic ovary syndrome J. Clin. Endocrinol. Metab. 84 1999 3110 3116 (Pubitemid 30646930)
25. A.M. Venkatesan, A. Dunaif, and A. Corbould Insulin resistance in polycystic ovary syndrome: progress and paradoxes Recent Prog. Horm. Res. 56 2001 295 308
26. C. Rosas, F. Gabler, and D. Vantman et al. Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women Hum. Reprod. 25 2010 2870 2877
27. R. Fornes, P. Ormazabal, and C. Rosas et al. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia Mol. Med. 16 2010 129 136
28. M.C. Allemand, B.A. Irving, and Y.W. Asmann et al. Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes - a potential model for PCOS-related insulin resistance PLoS One 4 2009 e4274
29. D.R. Matthews, J.P. Hosker, and A.S. Rudenski et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
30. W.G. Duncombe The colorimetric micro-determination of non-esterified fatty acids in plasma Clin. Chim. Acta 9 1964 122 125
31. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
32. J.J. Luiken, D.P. Koonen, and J. Willems et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36 Diabetes 51 2002 3113 3119
33. A. Dunaif, J. Xia, and C.B. Book et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome J. Clin. Invest. 96 1995 801 810
34. M. Li, J.F. Youngren, and A. Dunaif et al. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators J. Clin. Endocrinol. Metab. 87 2002 4088 4093
35. P. Gual, Y. Le Marchand-Brustel, and J.F. Tanti Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 2005 99 109 (Pubitemid 40298772)
36. B. DeBosch, I. Treskov, and T.S. Lupu et al. Akt1 is required for physiological cardiac growth Circulation 113 2006 2097 2104
37. A.J. Muslin Akt2: a critical regulator of cardiomyocyte survival and metabolism Pediatr. Cardiol. 32 2011 317 322
38. Y.H. Chen, S. Heneidi, and J.M. Lee et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance Diabetes 62 2013 2278 2286
39. C. Montessuit, and R. Lerch Regulation and dysregulation of glucose transport in cardiomyocytes Biochim. Biophys. Acta 1833 2013 848 856
40. S.L. Coort, A. Bonen, and G.J. van der Vusse et al. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters Mol. Cell. Biochem. 299 2007 5 18 (Pubitemid 46767533)
41. F. Altamirano, C. Oyarce, and P. Silva et al. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway J. Endocrinol. 202 2009 299 307
42. C. Wilson, A. Contreras-Ferrat, and N. Venegas et al. Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes J. Cell. Physiol. 228 2013 2399 2407
43. M. Jensterle, A. Janez, and B. Mlinar et al. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome Eur. J. Endocrinol. 158 2008 793 801 (Pubitemid 351837367)
44. E. Lizotte, S.A. Grandy, and A. Tremblay et al. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart Cell. Physiol. Biochem. 23 2009 75 86
45. K.L. Golden, J.D. Marsh, and Y. Jiang Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes Horm. Metab. Res. 36 2004 197 202 (Pubitemid 38626405)